Uterine Transplant: A Risk to Life or a Chance for Life?

14Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Being inherently different from any other lifesaving organ transplant, uterine transplantation does not aim at saving lives but supporting the possibility to generate life. Unlike the kidneys or the liver, the uterus is not specifically a vital organ. Given the non-lifesaving nature of this procedure, questions have been raised about its feasibility. The ethical dilemma revolves around whether it is worth placing two lives at risk related to surgery and immunosuppression, amongst others, to enable a woman with absolute uterine factor infertility to experience the presence of an organ enabling childbirth. In the year 2000, the first uterine transplantation, albeit unsuccessful, was performed in Saudi Arabia from where it has spread to the rest of the world including Sweden, the United States and now recently India. The procedure is, however, still in the preclinical stages and several ethical, legal, social and religious concerns are yet to be addressed before it can be integrated into the clinical setting as standard of care for women with absolute uterine factor infertility.

Cite

CITATION STYLE

APA

Taneja, A., Das, S., Hussain, S. A., Madadin, M., Lobo, S. W., Fatima, H., & Menezes, R. G. (2019). Uterine Transplant: A Risk to Life or a Chance for Life? Science and Engineering Ethics, 25(2), 635–642. https://doi.org/10.1007/s11948-018-0018-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free